Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

670 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
Takahashi M, Tsuchikawa T, Hiwasa T, Nakamura T, Hontani K, Kushibiki T, Inoko K, Takano H, Hatanaka Y, Matsushita K, Matsubara H, Hoshino T, Ohtsuka M, Shimada H, Tanaka K, Nakanishi Y, Asano T, Noji T, Okamura K, Shichinohe T, Hirano S. Takahashi M, et al. Among authors: hatanaka y. Oncol Rep. 2023 Feb;49(2):34. doi: 10.3892/or.2022.8471. Epub 2022 Dec 23. Oncol Rep. 2023. PMID: 36562381
[No title available]
[No authors listed] [No authors listed] PMID: 37543548
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.
Kikuchi Y, Shimada H, Hatanaka Y, Kinoshita I, Ikarashi D, Nakatsura T, Kitano S, Naito Y, Tanaka T, Yamashita K, Oshima Y, Nanami T. Kikuchi Y, et al. Among authors: hatanaka y. Int J Clin Oncol. 2024 Jan;29(1):1-19. doi: 10.1007/s10147-023-02430-x. Epub 2023 Nov 29. Int J Clin Oncol. 2024. PMID: 38019341
Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas.
Yamamoto H, Nakanishi Y, Mitsuhashi T, Hatanaka Y, Hatanaka K, Nange A, Yoshida Y, Ino N, Go M, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Murakami S, Ebihara Y, Kurashima Y, Shichinohe T, Hirano S. Yamamoto H, et al. Among authors: hatanaka k, hatanaka y. Ann Surg Oncol. 2024 Mar;31(3):2090-2100. doi: 10.1245/s10434-023-14638-2. Epub 2023 Dec 5. Ann Surg Oncol. 2024. PMID: 38052736
Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model.
Takeuchi Y, Wang Y, Sasaki K, Sato O, Tsuchikawa T, Wang L, Amaishi Y, Okamoto S, Mineno J, Hirokawa Y, Hatanaka KC, Hatanaka Y, Kato T, Shiku H, Hirano S. Takeuchi Y, et al. Among authors: hatanaka kc, hatanaka y. Biomed Pharmacother. 2024 Jan;170:116052. doi: 10.1016/j.biopha.2023.116052. Epub 2023 Dec 22. Biomed Pharmacother. 2024. PMID: 38141280 Free article.
Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma.
Fukuda J, Kosuge S, Satoh Y, Sekiya S, Yamamura R, Ooshio T, Hirata T, Sato R, Hatanaka KC, Mitsuhashi T, Nakamura T, Matsuno Y, Hatanaka Y, Hirano S, Sonoshita M. Fukuda J, et al. Among authors: hatanaka kc, hatanaka y. Cancer Sci. 2024 Apr;115(4):1333-1345. doi: 10.1111/cas.16100. Epub 2024 Feb 6. Cancer Sci. 2024. PMID: 38320747 Free PMC article.
Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model.
Niwa H, Nakamura T, Kushiya H, Kuraya T, Inoko K, Inagaki A, Suzuki T, Sasaki K, Tsuchikawa T, Hiraoka K, Shichinohe T, Hatanaka Y, Jolly DJ, Kasahara N, Hirano S. Niwa H, et al. Among authors: hatanaka y. Cancer Gene Ther. 2024 Sep;31(9):1390-1401. doi: 10.1038/s41417-024-00810-7. Epub 2024 Jul 23. Cancer Gene Ther. 2024. PMID: 39039195
Survivin as a therapeutic target for neuroendocrine neoplasms.
Hane Y, Tsuchikawa T, Nakamura T, Hatanaka KC, Sasaki K, Kawai N, Takeuchi S, Tanaka K, Nakanishi Y, Asano T, Noji T, Shichinohe T, Hatanaka Y, Hirohshi Y, Torigoe T, Hirano S. Hane Y, et al. Among authors: hatanaka y. Neuroendocrinology. 2025 Jan 2:1-31. doi: 10.1159/000543270. Online ahead of print. Neuroendocrinology. 2025. PMID: 39746333
Expression Analysis of Early Metastatic Seeding of Colorectal Cancer.
Sawada A, Ohira M, Hatanaka KC, Matsui H, Ichikawa N, Yoshida T, Fukai M, Matsuno Y, Homma S, Hatanaka Y, Taketomi A. Sawada A, et al. Among authors: hatanaka kc, hatanaka y. Ann Surg Oncol. 2024 Mar;31(3):2101-2113. doi: 10.1245/s10434-023-14714-7. Epub 2023 Dec 8. Ann Surg Oncol. 2024. PMID: 38063988
670 results